Like many of its peers in the contract clinical research sector, data management specialist Phase Forward put in another bumper financial performance in the second quarter headed by a 30 per cent hike in revenues to $41m.
Newly-released data appears to add weight to the case for
microdosing as a means to more accurately predict pharmacological
dose absorption, metabolism, distribution and elimination (ADME)
and pharmacokinetic (PK) outcomes in drug...
As eClinical gathers momentum, Outsourcing-Pharma.com spoke to two
contract research organisations (CROs), Icon and Parexel, to get
their views on the present and future of these emerging
Two major bioscience industry trade associations have called for
changes to be made to the European clinical trials directive in
order to bring about "harmonisation, transparency and consistency"
in this area across the...
Adaptive trials were a hot topic at this year's Drug Information
Association (DIA) Annual Meeting, held in Atlanta. The first of a
free seminar series on the subject will also be run by three
industry pioneers next week.